Akero Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
AKRO Nasdaq 8731 https://www.akerotx.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Akero Therapeutics Inc

Akero Therapeutics Appoints Patrick Lamy as Senior Vice President, Commercial Strategy - Jan 10th, 2023 1:00 pm
Akero Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference - Jan 4th, 2023 1:00 pm
Akero Therapeutics Outlines Expected 2023 Milestones For Lead NASH Program - Dec 22nd, 2022 12:44 pm
Akero Therapeutics Completes Enrollment of Phase 2b SYMMETRY Study and Announces Expected 2023 Milestones - Dec 21st, 2022 9:01 pm
Madrigal (MDGL) Soars as Resmetirom Meets Goal in NASH Study - Dec 20th, 2022 4:15 pm
Efruxifermin Granted FDA Breakthrough Therapy Designation for NASH - Dec 8th, 2022 12:00 pm
Akero Therapeutics, Inc.'s (NASDAQ:AKRO) large institutional owners must be happy as stock continues to impress, up 5.6% over the past week - Nov 13th, 2022 12:46 pm
Akero Therapeutics to Present at Upcoming Healthcare Conferences in November - Nov 10th, 2022 9:05 pm
Are Medical Stocks Lagging Akero Therapeutics (AKRO) This Year? - Nov 7th, 2022 2:40 pm
Akero Therapeutics to Present Late-Breaking Oral and Poster presentations on EFX Today at AASLD’s The Liver Meeting® 2022 - Nov 7th, 2022 12:30 pm
Akero Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update - Nov 4th, 2022 11:00 am
10 Best Small-Cap Stocks To Buy Now - Nov 3rd, 2022 10:53 pm
Novo Nordisk's (NVO) Q3 Earnings & Revenues Beat Estimates - Nov 2nd, 2022 3:14 pm
Gilead (GILD) Inks Deal for Gene Platform in Blood Cancers - Oct 21st, 2022 4:27 pm
AbbVie (ABBV) to Boost Immunology Pipeline With New Acquisition - Oct 21st, 2022 4:06 pm
Are Medical Stocks Lagging AVEO Pharmaceuticals (AVEO) This Year? - Oct 21st, 2022 1:40 pm
Why J.P. Morgan Believes These 3 Stocks Are Attractive in the Current Market - Oct 12th, 2022 12:56 am
Akero Therapeutics to Present at the H.C. Wainwright 6th Annual NASH Investor Conference - Oct 11th, 2022 8:01 pm
Is Akero Therapeutics (AKRO) Outperforming Other Medical Stocks This Year? - Oct 5th, 2022 1:40 pm
Akero Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares - Sep 19th, 2022 8:01 pm